Similar articles

• The effects of bromoacetylalprenololmenthane on the responses to isoprenaline of the left ventricle from normo-, prehyper- and hypertensive rats.

  Doggrell SA, Mistry DN, Henderson CJ. Doggrell SA, et al. J Auton Pharmacol. 1997 Jun;17(3):183-90. doi: 10.1046/j.1365-2680.1997.00454.x. J Auton Pharmacol. 1997. PMID: 9278778
• Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.

  Sato Y, Kurose H, Nagao T. Sato Y, et al. Jpn J Pharmacol. 1997 Apr;73(4):325-32. doi: 10.1254/jjp.73.325. Jpn J Pharmacol. 1997. PMID: 9165369
• The effect of alprenolol on the beta-receptor and adenylate cyclase activity in rabbit heart membranes.

  Tkachuk VA, Wollemann M. Tkachuk VA, et al. Mol Pharmacol. 1981 Jul;20(1):224-6. Mol Pharmacol. 1981. PMID: 6270534 No abstract available.
• Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.

  Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ. Molenaar P, et al. Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1020-8. doi: 10.1111/j.1440-1681.2007.04730.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17714089 Review.
• Pharmacological properties of beta 3-adrenoceptors.

  Nisoli E, Carruba MO. Nisoli E, et al. Trends Pharmacol Sci. 1997 Jul;18(7):257-8. Trends Pharmacol Sci. 1997. PMID: 9253858 Review. No abstract available.